P Elliott Miller1, Alexander Thomas2, Thomas J Breen3, Fouad Chouairi4, Yukiko Kunitomo2, Faisal Aslam2, Abdulla A Damluji5, Nandan S Anavekar3, Joseph G Murphy3, Sean van Diepen6, Gregory W Barsness3, Joseph Brennan4, Jacob Jentzer7. 1. Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Conn; Yale National Clinicians Scholar Program, New Haven, Conn. Electronic address: Elliott.Miller@yale.edu. 2. Department of Internal Medicine, Yale School of Medicine, New Haven, Conn. 3. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn. 4. Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Conn. 5. Inova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, Va; Division of Cardiology, Johns Hopkins Hospital, Baltimore, Md. 6. Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. 7. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minn.
Abstract
BACKGROUND: Current cardiac intensive care unit (CICU) practice has seen an increase in patient complexity, including an increase in noncardiac organ failure, critical care therapies, and comorbidities. We sought to describe the changing epidemiology of noncardiac multimorbidity in the CICU population. METHODS: We analyzed consecutive unique patient admissions to 2 geographically distant tertiary care CICUs (n = 16,390). We assessed for the prevalence of 0, 1, 2, and ≥3 noncardiac comorbidities (diabetes, chronic lung, liver, and kidney disease, cancer, and stroke/transient ischemic attack) and their associations with hospital and postdischarge 1-year mortality using multivariable logistic regression. RESULTS: The prevalence of 0, 1, 2, and ≥3 noncardiac comorbidities was 37.7%, 31.4%, 19.9%, and 11.0%, respectively. Increasing noncardiac comorbidities were associated with a stepwise increase in mortality, length of stay, noncardiac indications for ICU admission, and increased utilization of critical care therapies. After multivariable adjustment, compared with those without noncardiac comorbidities, there was an increased hospital mortality for patients with 1 (odds ratio [OR] 1.30; 95% confidence interval [CI], 1.10-1.54, P = .002), 2 (OR 1.47; 95% CI, 1.22-1.77, P < .001), and ≥3 (OR 1.79; 95% CI, 1.44-2.22, P < .001) noncardiac comorbidities. Similar trends for each additional noncardiac comorbidity were seen for postdischarge 1-year mortality (P < .001, all). CONCLUSIONS: In 2 large contemporary CICU populations, we found that noncardiac multimorbidity was highly prevalent and a strong predictor of short- and long-term adverse clinical outcomes. Further study is needed to define the best care pathways for CICU patients with acute cardiac illness complicated by noncardiac multimorbidity.
BACKGROUND: Current cardiac intensive care unit (CICU) practice has seen an increase in patient complexity, including an increase in noncardiac organ failure, critical care therapies, and comorbidities. We sought to describe the changing epidemiology of noncardiac multimorbidity in the CICU population. METHODS: We analyzed consecutive unique patient admissions to 2 geographically distant tertiary care CICUs (n = 16,390). We assessed for the prevalence of 0, 1, 2, and ≥3 noncardiac comorbidities (diabetes, chronic lung, liver, and kidney disease, cancer, and stroke/transient ischemic attack) and their associations with hospital and postdischarge 1-year mortality using multivariable logistic regression. RESULTS: The prevalence of 0, 1, 2, and ≥3 noncardiac comorbidities was 37.7%, 31.4%, 19.9%, and 11.0%, respectively. Increasing noncardiac comorbidities were associated with a stepwise increase in mortality, length of stay, noncardiac indications for ICU admission, and increased utilization of critical care therapies. After multivariable adjustment, compared with those without noncardiac comorbidities, there was an increased hospital mortality for patients with 1 (odds ratio [OR] 1.30; 95% confidence interval [CI], 1.10-1.54, P = .002), 2 (OR 1.47; 95% CI, 1.22-1.77, P < .001), and ≥3 (OR 1.79; 95% CI, 1.44-2.22, P < .001) noncardiac comorbidities. Similar trends for each additional noncardiac comorbidity were seen for postdischarge 1-year mortality (P < .001, all). CONCLUSIONS: In 2 large contemporary CICU populations, we found that noncardiac multimorbidity was highly prevalent and a strong predictor of short- and long-term adverse clinical outcomes. Further study is needed to define the best care pathways for CICU patients with acute cardiac illness complicated by noncardiac multimorbidity.
Authors: Abhinav Sharma; Xin Zhao; Bradley G Hammill; Adrian F Hernandez; Gregg C Fonarow; G Michael Felker; Clyde W Yancy; Paul A Heidenreich; Justin A Ezekowitz; Adam D DeVore Journal: Circ Heart Fail Date: 2018-06 Impact factor: 8.790
Authors: Jason N Katz; Bimal R Shah; Elizabeth M Volz; John R Horton; Linda K Shaw; L Kristin Newby; Christopher B Granger; Daniel B Mark; Robert M Califf; Richard C Becker Journal: Crit Care Med Date: 2010-02 Impact factor: 7.598
Authors: Courtney E Bennett; R Scott Wright; Jacob Jentzer; Ognjen Gajic; Dennis H Murphree; Joseph G Murphy; Sunil V Mankad; Brandon M Wiley; Malcolm R Bell; Gregory W Barsness Journal: J Crit Care Date: 2018-12-24 Impact factor: 3.425
Authors: Shashank S Sinha; Michael W Sjoding; Devraj Sukul; Hallie C Prescott; Theodore J Iwashyna; Hitinder S Gurm; Colin R Cooke; Brahmajee K Nallamothu Journal: Circ Cardiovasc Qual Outcomes Date: 2017-08
Authors: Vasken Keleshian; Kianoush B Kashani; Panagiotis Kompotiatis; Gregory W Barsness; Jacob C Jentzer Journal: J Crit Care Date: 2019-11-05 Impact factor: 3.425
Authors: Michael W Rich; Deborah A Chyun; Adam H Skolnick; Karen P Alexander; Daniel E Forman; Dalane W Kitzman; Mathew S Maurer; James B McClurken; Barbara M Resnick; Win K Shen; David L Tirschwell Journal: J Am Coll Cardiol Date: 2016-04-11 Impact factor: 24.094
Authors: Jacob C Jentzer; Courtney Bennett; Brandon M Wiley; Dennis H Murphree; Mark T Keegan; Ognjen Gajic; R Scott Wright; Gregory W Barsness Journal: J Am Heart Assoc Date: 2018-03-10 Impact factor: 5.501
Authors: Michael Böhm; Andrew J S Coats; Ingrid Kindermann; Ilaria Spoletini; Giuseppe Rosano Journal: Eur Heart J Suppl Date: 2019-12-31 Impact factor: 1.803
Authors: Alexander Thomas; Sean van Diepen; Rachel Beekman; Shashank S Sinha; Samuel B Brusca; Carlos L Alviar; Jacob Jentzer; Erin A Bohula; Jason N Katz; Andi Shahu; Christopher Barnett; David A Morrow; Emily J Gilmore; Michael A Solomon; P Elliott Miller Journal: JACC Adv Date: 2022-08-26